NASDAQ Companies

– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline – – […]

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC (“LPL Financial”), a wholly owned subsidiary of LPL Financial […]

MALVERN, Pa., March 20, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on […]

A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the […]

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second […]

WESTBROOK, Maine, March 20, 2025 (GLOBE NEWSWIRE) — Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of […]

– Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination […]

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with […]

LIBERTY LAKE, Wash., March 20, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for energy […]

– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid […]